TPC
LEGN icon

Tiger Pacific Capital’s Legend Biotech LEGN Stock Holding History

Tiger Pacific Capital’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-222,000
Closed -$7.22M – 15
2024
Q4 		$7.22M Buy
222,000
+53,100
+31% +$2.2M 1.93% 11
2024
Q3 		$8.23M Buy
+168,900
New +$9M 1.57% 12

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Tiger Pacific Capital's LEGN Position: Q1 2025 in Review

Tiger Pacific Capital sold out of Legend Biotech (LEGN) in Q1 2025, closing a stake of 222,000 shares — an estimated $7.22M sold.

Tiger Pacific Capital first reported a position in LEGN in Q3 2024 and held it in 2 quarters. The position peaked at $8.23M in Q3 2024. 208 funds tracked by Wall St. Rank hold LEGN as of Q1 2025.

  • Tiger Pacific Capital reported no remaining Legend Biotech position as of Q1 2025 after selling out during the quarter.
  • Tiger Pacific Capital sold 222,000 Legend Biotech shares in Q1 2025, an estimated $7.22M.
  • Tiger Pacific Capital first reported a position in Legend Biotech in Q3 2024 and held it in 2 quarters.
  • Tiger Pacific Capital's Legend Biotech position peaked at $8.23M in Q3 2024.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2025.

Based on Tiger Pacific Capital's 13F filing for Q1 2025, filed 15 May 2025.